Polish & Viral Filtration Webinars

  1. Scale-Up Strategies: Mammalian, Microbial Process Commonalities 3/29/2021

    This webinar offers a general understanding of the concepts and tools required to successfully scale a process from bench to manufacturing.

  2. Predicting LRV Through The Use Of A Non-Infectious MVM Surrogate 3/23/2021

    Discussed here are results from studies that utilized a non-infectious Mock Virus Particle as an MVM surrogate, demonstrating the value to be gained from a QbD approach during process optimization.

  3. The Blazar® Platform In A Minute 3/12/2021

    The Blazar® Rodent Panel from the BioReliance® portfolio can speed cell line characterization and bulk harvest lot release testing. This degenerate PCR-based method accelerates characterization by reducing timelines by up to 80% and replaces the use of animals.

  4. Virus Removal: Planova BioEX 3/26/2020

    Planova BioEX provides assurance beyond expectation with superior filtration performance, combined with its robust virus removability and excellent scalability.

  5. How To Ensure Biosafety Of Novel Viral Therapies 11/7/2019

    While no viral contamination has been reported so far for novel viral therapies, it is important to learn from historical experience and leverage improved manufacturing and testing methods to increase their safety. 

  6. Rapid Methodologies For Biosafety Testing Of Biologic Therapeutics 10/23/2018

    This webinar explores how rapid methodologies are being used to not only accelerate this process, but also enhance quality by reducing testing complexity.

  7. What Is Mixed-Mode Chromatography? 4/12/2016

    There are a variety of advantages of mixed-mode interactions have been observed beyond simply finer discrimination between product and impurities.

  8. Optimized Purity Of A Monoclonal Antibody, Carsten Voß Video 4/12/2016

    Purity, recovery, and elution volume are important factors and parameters when screening multiple media (resins) for the development of efficient, robust, and economical production processes.

  9. Exploring An Integrated Solution For AAV Vector Clinical Production

    Every choice is critical in AAV vector production. Experts share how to make the right choices, from the process and cell line, to off-the-shelf plasmids and qualified analytical methods.

  10. Designing An Advanced Protein A Chromatography Resin

    The relationships and considerations of bead structure, pore structure, surface chemistries and ligand design on affinity resin performance targets.